Plandai Biotechnology Inc (PLPL) financial statements (2021 and earlier)

Company profile

Business Address 1451 NORTH 200 EAST
LOGAN, UT 98102
State of Incorp.
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2016
Q3
12/31/2015
Q2
9/30/2015
Q1
6/30/2015
Q4
3/31/2015
Q3
12/31/2014
Q2
9/30/2014
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8146341289311,476
Cash and cash equivalents8146341289311,476
Receivables4819151771212
Inventory, net of allowances, customer advances and progress billings544562432
Inventory544562432
Other current assets6696  135195238
Other undisclosed current assets  116365   
Total current assets:1761741434182731,1411,729
Noncurrent Assets
Property, plant and equipment6,2766,0456,9178,0109,4689,6069,139
Other noncurrent assets1089292179720
Other undisclosed noncurrent assets65606775757779
Total noncurrent assets:6,4496,1987,0758,0869,6239,7569,218
TOTAL ASSETS:6,6266,3717,2188,5059,89610,89610,947
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:476467442316216149223
Accrued liabilities      66
Interest and dividends payable598492390289198122 
Other undisclosed accounts payable and accrued liabilities(122)(25)51281927157
Debt13,94213,33513,955(14,526)7,9507,400 
Derivative instruments and hedges, liabilities34872     
Due to related parties15131416 17 
Other undisclosed current liabilities65749339029,34119812266
Total current liabilities:15,43814,37914,80115,1478,3647,688289
Noncurrent Liabilities
Long-term debt and lease obligation    5,6696,55712,962
Long-term debt, excluding current maturities    5,6696,55712,962
Liabilities, other than long-term debt1,6341,4661,5591,674178  
Deferred revenue and credits1,5011,3411,4181,514   
Other liabilities133126141160178  
Other undisclosed noncurrent liabilities    1,4951,4511,386
Total noncurrent liabilities:1,6341,4661,5591,6747,3428,00814,348
Total liabilities:17,07315,84616,36016,82115,70615,69614,638
Stockholders' equity
Stockholders' equity attributable to parent, including:(8,372)(7,482)(7,212)(6,499)(4,281)(3,391)(2,381)
Common stock18171716161313
Common stock, value, subscriptions501359045 2,1501,830
Additional paid in capital30,68530,32830,21630,12529,73022,34322,302
Accumulated deficit(39,324)(38,236)(37,498)(36,309)(33,909)(27,750)(26,595)
Other undisclosed stockholders' equity attributable to parent199274(36)(376)(118)(147)69
Stockholders' equity attributable to noncontrolling interest(2,075)(1,993)(1,930)(1,818)(1,530)(1,409)(1,310)
Total stockholders' equity:(10,447)(9,475)(9,142)(8,317)(5,810)(4,800)(3,691)
TOTAL LIABILITIES AND EQUITY:6,6266,3717,2188,5059,89610,89610,947

Income statement (P&L) ($ in thousands)

3/31/2016
Q3
12/31/2015
Q2
9/30/2015
Q1
6/30/2015
Q4
3/31/2015
Q3
12/31/2014
Q2
9/30/2014
Q1
Revenues100514129226726
Other income    13
Cost of revenue
(Cost of Goods and Services Sold)
   960(581)(234)(175)
Other undisclosed gross profit   (453)3991815
Gross profit:1005141536(159)(148)(134)
Operating expenses(825)(749)(920)(1,092)(5,830)(1,101)(1,341)
Other undisclosed operating income (loss)   76 91(0)
Operating loss:(725)(699)(879)(479)(5,989)(1,159)(1,474)
Nonoperating income (expense) 276 (790)145(216)(246)
Foreign currency transaction gain (loss), before tax    145(216)(246)
Other nonoperating income 276     
Interest and debt expense(375)(324)(310)550(296)(134)(118)
Net loss:(1,100)(747)(1,189)(720)(6,140)(1,509)(1,838)
Net income (loss) attributable to noncontrolling interest8365113683(121)99(27)
Other undisclosed net income (loss) attributable to parent(77)(68)(113)(1,891)(12)1171,254
Net loss available to common stockholders, diluted:(1,095)(750)(1,189)(1,927)(6,273)(1,293)(611)

Comprehensive Income ($ in thousands)

3/31/2016
Q3
12/31/2015
Q2
9/30/2015
Q1
6/30/2015
Q4
3/31/2015
Q3
12/31/2014
Q2
9/30/2014
Q1
Net loss:(1,100)(747)(1,189)(720)(6,140)(1,509)(1,838)
Comprehensive loss:(1,100)(747)(1,189)(720)(6,140)(1,509)(1,838)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest8365113683(121)99(27)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(70)321340(1,539)255 981
Comprehensive loss, net of tax, attributable to parent:(1,087)(361)(736)(1,576)(6,006)(1,410)(884)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: